Raphael Pharmaceutical (RAPH) Operating Income (QoQ) (2021 - 2024)
Raphael Pharmaceutical (RAPH) Operating Income (QoQ) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -23.51% |
| Sep 30, 2024 | -28.11% |
| Jun 30, 2024 | 54.48% |
| Mar 31, 2024 | -508.21% |
| Dec 31, 2023 | 118.38% |
| Sep 30, 2023 | -73.99% |
| Jun 30, 2023 | -62.40% |
| Mar 31, 2023 | 76.63% |
| Dec 31, 2022 | 22.58% |
| Sep 30, 2022 | -133.01% |
| Jun 30, 2022 | -249.71% |
| Mar 31, 2022 | 69.51% |
| Dec 31, 2021 | -37.32% |
| Sep 30, 2021 | -8.57% |
| Jun 30, 2021 | -52.78% |
| Mar 31, 2021 | -11.01% |